BD Board Declares Dividend
BD (Becton, Dickinson and Company), a leading global medical technology company, has announced its latest quarterly dividend declaration. The company's Board of Directors has approved a quarterly dividend of $1.04 per common share.
Key details of the dividend announcement:
- Payment Date: June 30, 2025
- Record Date: June 9, 2025
- Annual Dividend Rate: $4.16 per share
This dividend announcement from the NYSE-listed company (BDX) demonstrates BD's commitment to providing regular returns to its shareholders.
BD (Becton, Dickinson and Company), un'importante azienda globale nel settore della tecnologia medica, ha annunciato la sua più recente dichiarazione di dividendo trimestrale. Il Consiglio di Amministrazione ha approvato un dividendo trimestrale di 1,04 $ per azione ordinaria.
Dettagli principali dell'annuncio del dividendo:
- Data di pagamento: 30 giugno 2025
- Data di registrazione: 9 giugno 2025
- Aliquota annuale del dividendo: 4,16 $ per azione
Questo annuncio di dividendo da parte della società quotata alla NYSE (BDX) dimostra l'impegno di BD a fornire rendimenti regolari ai propri azionisti.
BD (Becton, Dickinson and Company), una empresa líder global en tecnología médica, ha anunciado su última declaración de dividendo trimestral. La Junta Directiva de la compañía aprobó un dividendo trimestral de 1,04 $ por acción común.
Detalles clave del anuncio del dividendo:
- Fecha de pago: 30 de junio de 2025
- Fecha de registro: 9 de junio de 2025
- Tasa anual de dividendo: 4,16 $ por acción
Este anuncio de dividendo de la empresa cotizada en la NYSE (BDX) demuestra el compromiso de BD de ofrecer retornos regulares a sus accionistas.
BD (Becton, Dickinson and Company)는 글로벌 의료기술 선도 기업으로, 최신 분기 배당 선언을 발표했습니다. 회사 이사회는 보통주 1주당 1.04달러의 분기 배당금을 승인했습니다.
배당 발표 주요 내용:
- 지급일: 2025년 6월 30일
- 기준일: 2025년 6월 9일
- 연간 배당률: 주당 4.16달러
NYSE에 상장된 이 회사(BDX)의 이번 배당 발표는 BD가 주주들에게 정기적인 수익을 제공하겠다는 의지를 보여줍니다.
BD (Becton, Dickinson and Company), une entreprise mondiale de premier plan dans le domaine de la technologie médicale, a annoncé sa dernière déclaration de dividende trimestriel. Le conseil d'administration de la société a approuvé un dividende trimestriel de 1,04 $ par action ordinaire.
Détails clés de l'annonce du dividende :
- Date de paiement : 30 juin 2025
- Date de référence : 9 juin 2025
- Taux de dividende annuel : 4,16 $ par action
Cette annonce de dividende de la société cotée au NYSE (BDX) témoigne de l'engagement de BD à offrir des rendements réguliers à ses actionnaires.
BD (Becton, Dickinson and Company), ein weltweit führendes Medizintechnikunternehmen, hat seine jüngste Quartalsdividendenbekanntgabe veröffentlicht. Der Vorstand des Unternehmens hat eine Quartalsdividende von 1,04 $ pro Stammaktie genehmigt.
Wichtige Details zur Dividendenankündigung:
- Zahltag: 30. Juni 2025
- Stichtag: 9. Juni 2025
- Jährliche Dividendenrate: 4,16 $ pro Aktie
Diese Dividendenankündigung des an der NYSE notierten Unternehmens (BDX) zeigt das Engagement von BD, seinen Aktionären regelmäßige Erträge zu bieten.
- Consistent dividend payment maintained at $1.04 per share quarterly
- Annual dividend rate of $4.16 per share indicates strong cash flow position
- None.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
VP, Public Relations | Sr. Director, Investor Relations |
858.617.2361 | 201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-board-declares-dividend-302441798.html
SOURCE BD (Becton, Dickinson and Company)